Holen Sie sich die Stockscreener-App
54.09
0.24%
-0.13
Handel nachbörslich:
54.00
-0.09
-0.17%
Schlusskurs vom Vortag:
$54.22
Offen:
$53.8
24-Stunden-Volumen:
637.50K
Relative Volume:
1.78
Marktkapitalisierung:
$1.10B
Einnahmen:
$1.77M
Nettoeinkommen (Verlust:
$-123.74M
KGV:
-5.8986
EPS:
-9.17
Netto-Cashflow:
$-95.21M
1W Leistung:
-8.66%
1M Leistung:
+25.30%
6M Leistung:
-29.34%
1J Leistung:
-5.02%
1-Tages-Spanne:
$53.00
$55.94
1-Wochen-Bereich:
$53.00
$60.00
52-Wochen-Spanne:
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Firmenname
Praxis Precision Medicines Inc
Sektor
Branche
Telefon
617-300-8460
Adresse
99 HIGH STREET, 30TH FLOOR, BOSTON
Vergleichen Sie PRAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
54.09 | 1.10B | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-03 | Bestätigt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-08-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-24 | Eingeleitet | Needham | Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Buy |
| 2024-05-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-09-19 | Eingeleitet | Truist | Buy |
| 2022-06-06 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-08-26 | Eingeleitet | BofA Securities | Buy |
| 2021-04-26 | Eingeleitet | William Blair | Outperform |
| 2020-11-11 | Eingeleitet | Wedbush | Outperform |
| 2020-11-10 | Eingeleitet | Cowen | Outperform |
| 2020-11-10 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
What is the dividend policy of Praxis Precision Medicines Inc. stockBuild wealth steadily with proven stock picks - jammulinksnews.com
What drives Praxis Precision Medicines Inc. stock priceCapitalize on emerging trends for profits - jammulinksnews.com
Published on: 2025-08-03 18:33:45 - jammulinksnews.com
What is the risk reward ratio of investing in Praxis Precision Medicines Inc. stockInvest confidently with professional market insights - jammulinksnews.com
What is Praxis Precision Medicines Inc. company’s growth strategyInvest smarter with actionable stock recommendations - jammulinksnews.com
What makes Praxis Precision Medicines Inc. stock price move sharplyInvest confidently with professional market insights - jammulinksnews.com
How many analysts rate Praxis Precision Medicines Inc. as a “Buy”Maximize your gains with professional insights - jammulinksnews.com
Should I hold or sell Praxis Precision Medicines Inc. stock in 2025Capitalize on proven trading setups - jammulinksnews.com
Is Praxis Precision Medicines Inc. stock overvalued or undervaluedGet real-time alerts on high-potential stocks - jammulinksnews.com
What analysts say about Praxis Precision Medicines Inc. stockExceptional earning trajectories - jammulinksnews.com
Published on: 2025-08-03 14:54:31 - jammulinksnews.com
Does Praxis Precision Medicines Inc. stock perform well during market downturnsBuild a diversified portfolio for sustainable growth - jammulinksnews.com
How does Praxis Precision Medicines Inc. compare to its industry peersBuild wealth steadily with smart stock selection - jammulinksnews.com
Published on: 2025-08-03 04:23:46 - jammulinksnews.com
What are Praxis Precision Medicines Inc. company’s key revenue driversFree Stock Market Mentorship - jammulinksnews.com
What are analysts’ price targets for Praxis Precision Medicines Inc. in the next 12 monthsDiscover high-impact investment opportunities - jammulinksnews.com
Sentiment analysis tools applied to Praxis Precision Medicines Inc.Investment Timing Strategy with Market Filters - Newser
Should you hold or exit Praxis Precision Medicines Inc. nowLong-Term Safety Investment Analysis Report - Newser
What indicators show strength in Praxis Precision Medicines Inc.Loss Limitation Strategy Based on Analysis - Newser
Will Praxis Precision Medicines Inc. see short term momentumFree Reversal Alert Based on RSI Indicator - Newser
Is it too late to sell Praxis Precision Medicines Inc.Market Timing Strategy with Technical Filters - Newser
Why Praxis Precision Medicines Inc. stock attracts strong analyst attentionTrend Reversal Probability Forecast Update - Newser
Will Praxis Precision Medicines Inc. stock split in the near futureLow Volatility Stock Analysis With Confidence - Newser
Is Praxis Precision Medicines Inc. stock entering bullish territoryShort-Term Growth Watch with Signal Prediction - Newser
Applying sector rotation models to Praxis Precision Medicines Inc.3-Day Market Movement Forecast Analysis - Newser
Praxis Precision Medicines’ (PRAX) “Buy” Rating Reaffirmed at Chardan Capital - Defense World
Detecting price anomalies in Praxis Precision Medicines Inc. with AIMachine Learning Intraday Signal Forecast - Newser
Praxis Precision Medicines to Host Conference Call to Announce T - GuruFocus
PERCEPTIVE ADVISORS LLC Boosts Stake in Praxis Precision Medicines Inc, Highlighting Biotech Sector Potential - AInvest
Praxis Precision Medicines to Host Conference Call to - GlobeNewswire
Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results - Stock Titan
Chardan Capital Reiterates Buy Rating on PRAX with $80 Target | - GuruFocus
Buy Signal for Praxis Precision Medicines Inc. Stock Key Technical Indicators to WatchReal-Time Investment Signal Forecast with AI - Newser
How Praxis Precision Medicines Inc. stock performs during market volatilityFree Stock Selection With High Accuracy - Newser
Is Praxis Precision Medicines Inc. stock entering bullish territory Bollinger Band Squeeze and Expansion Analysis - Newser
How volatile is Praxis Precision Medicines Inc. stock compared to the marketUnlock powerful investment tools for free - jammulinksnews.com
Will Praxis Precision Medicines Inc. see short term momentum Buy Signal System Based on Price Action - Newser
Is it too late to sell Praxis Precision Medicines Inc. Free Growth Focused Entry Plan Suggestions - Newser
Finanzdaten der Praxis Precision Medicines Inc-Aktie (PRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):